KONINKLIJKE PHILIPS N.V. PHG

Koninklijke Philips NV es una empresa de tecnología de la salud con sede en los Países Bajos. Los segmentos de la compañía incluyen negocios de Salud Personal, negocios de Diagnóstico y Tratamiento, negocios de Cuidado Conectado e Informática de la Salud, Otros negocios de HealthTech y Artículos Heredados. El segmento de negocios de Salud Personal se dedica al continuo de la salud, ofreciendo soluciones integradas y conectadas que apoyan estilos de vida más saludables y aquellos que viven con enfermedades crónicas. El segmento de negocios de Diagnóstico y Tratamiento ofrece medicina de precisión, tratamiento y terapia. El segmento de negocios de Cuidado Conectado e Informática de la Salud proporciona soluciones digitales a consumidores, cuidadores y clínicos que facilitan la atención al permitir la medicina de precisión y la gestión de la salud de la población. El segmento de Otros negocios de HealthTech incluye elementos como innovación, negocios emergentes, regalías, entre otros. El segmento de Artículos Heredados consiste principalmente en costos de separación, asuntos legales heredados, costos de pensiones heredados, entre otros.

Con 40 acciones de PHG (USD 987,80) habrías recibido USD 39,60 en dividendos en los últimos 12 meses.

PHG separó parte de su negocio en una nueva empresa (spin-off) el 13 de mayo de 2026. Sus accionistas recibieron acciones de la nueva compañía, y por eso el precio histórico de PHG está ajustado.

• GlobeNewswire Inc. 30 sept

  Pacemaker/Defibrillator Lead Extraction Kit Market Forecast - 2034 | $1.92 Billion Opportunity Fueled by Minimally Invasive Care and Rising CIED Infections

  The global Pacemaker/Defibrillator Lead Extraction Kit market is projected to grow from USD 1.03 billion in 2025 to USD 1.92 billion by 2034, expanding at a CAGR of 7.2%. Growth is driven by rising CIED implantation volumes, increasing device-related infections, aging populations, and the shift toward minimally invasive procedures. Mechanical extraction systems lead with 46% market share, while hospitals account for 85% of revenue. North America dominates with 44% market share, while Asia-Pacific is expected to record the fastest regional growth.

  

• GlobeNewswire Inc. 25 sept

  Cardiorespiratory Assessment Units Market Poised for Growth Through 2035 as Advanced Technologies and Expanding Clinical Applications Create New Opportunities

  The global Cardiorespiratory Assessment Units Market is projected to grow from USD 1.48 billion in 2025 to USD 2.98 billion by 2035, expanding at a CAGR of 7.23%. Growth is driven by rising prevalence of COPD and heart failure, innovation in portable AI-enabled systems, and expanding remote care applications. However, high equipment costs and staffing requirements remain challenges. North America leads with 35.12% market share.

  

• GlobeNewswire Inc. 23 sept

  Exor Press Release - Buyback Launch

  Exor N.V. has launched a €500 million share buyback program to reduce share capital, starting with a first tranche of €125 million expected to be completed by end of November 2026. The program will be executed through a discretionary buyback agreement with a financial institution in compliance with market regulations.

  

• GlobeNewswire Inc. 17 sept

  Software as a Medical Device Market Set for Rapid Growth Through 2034 as AI Innovation, Digital Health Adoption, and Regulatory Advances Reshape the Competitive Landscape

  The global Software as a Medical Device (SaMD) market is projected to grow from USD 2.10 billion in 2025 to USD 8.90 billion by 2034, expanding at a CAGR of 17.4%. Growth is driven by AI-enabled diagnostics, digital therapeutics, cloud-based deployment, and maturing regulatory pathways. Diagnostic and screening software leads with 42% market share, while radiology applications dominate at 34%. North America holds 45% of the market, with Asia-Pacific expected to record the fastest growth.

  

• GlobeNewswire Inc. 16 sept

  Ultrasound AI Market Size to Surge to USD 22.03 Billion by 2035 at a CAGR of 26.62% – SNS Insider

  The global Ultrasound AI market is projected to grow from USD 2.09 billion in 2025 to USD 22.03 billion by 2035, with a CAGR of 26.62%. Growth is driven by deep learning advancements, point-of-care imaging adoption, and sonographer shortages. North America leads with 45.54% market share, while Asia-Pacific shows the fastest growth at 28.57% CAGR. Hardware dominates at 48% market share, with software as the fastest-growing segment.